Ann: LBT Presents at ASX Small & Microcap Conference, page-9

Just watched the presentation. I think it's great opportunity with relatively low risk. Market cap is only 26M, even in worst case scenario I'm sure they'll get taken over by likes of BD kiestra.. but hopefully things go well for them next couple of years. Most of the urine culture plates are negative even in hospital setting so I can see lots of labs adopting APAS and reduce scientists' time spent on reading every single plate.

Only thing that bothered me from the presentation was that Brent was saying 'Microbiologist' when he should've said 'scientist' or 'technician'. As far as I understand APAS technology rules out negative urine plates, urine plates are almost never read by microbiologist, it's done by scientist who's average salary is around $80k whereas microbiologists have minimum base salary of $150k. Huge difference.

All in all I think there's a huge potential here.. Good luck to you all